Skip to content

Aripiprazole Impurity 4

Aripiprazole Impurity 4

Product Description
CAT No.
ALN-A001034
CAS No.
1424857-63-5
Mol. F.
C36H42Cl2N4O4
Mol. Wt.
665.7
Stock
Please Inquire
Chemical Name : 2(1H)​-​Quinolinone, 7-​[4-​[4-​(2,​3-​dichlorophenyl)​-​1-​piperazinyl]​butoxy]​-​3,​4-​dihydro-​1-​[4-​[(1,​2,​3,​4-​tetrahydro-​2-​oxo-​7-​quinolinyl)​oxy]​butyl]​-; 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-1-[4-[(1,2,3,4-tetrahydro-2-oxo-7-quinolinyl)oxy]butyl]-2(1H)-quinolinone;
Smiles : O=C1N(CCCCOC2=CC=C(CCC(N3)=O)C3=C2)C4=C(C=CC(OCCCCN5CCN(C6=CC=CC(Cl)=C6Cl)CC5)=C4)CC1
Inchi : InChI=1S/C13H15NO2/c1-2-3-8-16-11-6-4-10-5-7-13(15)14-12(10)9-11/h2,4,6,9H,1,3,5,7-8H2,(H,14,15)

Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and In vivo studies

Haley McFall1 , Sandeep Sarabu1 , Vijaykumar Shankar1 , Suresh Bandari1 , S. Narasimha Murthy1 , Karl Kolter2 , Nigel Langley3 , Dong Wuk Kim4**, Michael A. RepkanInternational Journal of Pharmaceutics Volume 554, 10 January 2019, Pages 302-311

Molecular determinants of the intrinsic efficacy of the antipsychotic aripiprazole

Identification of Degradation Impurities in Aripiprazole Oral Solution Using LC-MS and Development of Validated Stability Indicating Method for Assay and Content of Two Preservatives by RP-HPLC

, Michael A. Repka – International Journal of Pharmaceutics Volume 554, 10 January 2019, Pages 302-311

Request For Quotation